Literature DB >> 30985086

Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes.

Stine Byberg1, Dorte Vistisen1, Lars Diaz1, Morten H Charles2, Javad Nouri Hajari1,3, Marianne Valerius1,3, Ellen Juul1,3, Marit E Jørgensen1,4, Henrik Lund-Andersen1,3.   

Abstract

PURPOSE: Diabetic retinopathy (DR) screening methods are costly, requiring specialized personnel and patient mydriasis. The Optos apparatus can be operated by nonspecialists and provides ultra-wide-field imaging, with 200° views of the retina in a single image. We compared DR grading obtained from Optos imaging with DR grading from conventional Topcon imaging.
METHODS: We conducted a cross-sectional study of 101 persons with diabetes who participated in the Addition-DK 10-year follow-up study. Retina fundus photos using both Optos and Topcon imaging were taken for both eyes. All photos were graded by specialist ophthalmologic nurses, using a modified version of the 'Proposed International Clinical DR severity scale'. We constructed frequency tables and assessed levels of agreement between Optos and Topcon gradings using weighted Kappa statistics, separately for peripheral and macular grading. We tested if the agreements between the two cameras were significantly different using a stratified Wilcoxon test.
RESULTS: Significantly, more lesions in the periphery were identified by Optos compared with Topcon (p < 0.01), resulting in a fair Kappa agreement of 0.21. We saw no significant differences in the grading of the macula region (p = 0.97) between the two cameras. Although only 7% of the macula image gradings differed between the cameras, the Kappa agreement of macula grading was only moderate (Kappa = 0.52).
CONCLUSION: The inter-camera agreement was acceptable for macula image grading, but only fair for peripheral grading, with Optos identifying more microvascular changes in the periphery. The clinical significance and impact on screening modality and frequency remain to be explored.
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetic retinopathy; screening; ultra-wide-field; validation

Mesh:

Year:  2019        PMID: 30985086     DOI: 10.1111/aos.14118

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  3 in total

1.  Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy.

Authors:  Aditya Verma; Ahmed Roshdy Alagorie; Kim Ramasamy; Jano van Hemert; N K Yadav; Rajeev R Pappuru; Adnan Tufail; Muneesawar Gupta Nittala; SriniVas R Sadda; Rajiv Raman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-27       Impact factor: 3.117

2.  Factors Affecting Predominantly Peripheral Lesion Identification and Grading.

Authors:  Mohamed Ashraf; Abdulrahman Rageh; Michael Gilbert; Dorothy Tolls; Alan Fleming; Ahmed Souka; Samir El-Baha; Jerry D Cavallerano; Jennifer K Sun; Lloyd Paul Aiello; Paolo S Silva
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.048

3.  Ultra-wide field swept-source optical coherence tomography angiography in patients with diabetes without clinically detectable retinopathy.

Authors:  Jingyuan Yang; Bilei Zhang; Erqian Wang; Song Xia; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2021-05-01       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.